CVS Health Return On Tangible Equity 2010-2025 | CVS

CVS Health return on tangible equity for the quarter ending March 31, 2025 was -12.28.

  • CVS Health average return on tangible equity for 2024 was -13.37, a 10.75% decline from 2023.
  • CVS Health average return on tangible equity for 2023 was -14.98, a 18.19% decline from 2022.
  • CVS Health average return on tangible equity for 2022 was -18.31, a 7.01% decline from 2021.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.

CVS Health Return On Tangible Equity 2010-2025 | CVS

  • CVS Health average return on tangible equity for 2024 was -13.37, a 10.75% decline from 2023.
  • CVS Health average return on tangible equity for 2023 was -14.98, a 18.19% decline from 2022.
  • CVS Health average return on tangible equity for 2022 was -18.31, a 7.01% decline from 2021.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$133.5B
Elevance Health (ELV)$96.1B
Cencora (COR)$55.6B
DiDi Global (DIDIY)$20.3B
Natera (NTRA)$20B
BioMerieux (BMXMF)$15.6B
Solventum (SOLV)$11.5B
ICON (ICLR)$11.3B
EUROFINS SCIENT (ERFSF)$11.1B
Revvity (RVTY)$11B
CochLear (CHEOY)$10.9B
Avantor (AVTR)$10.3B
Doximity (DOCS)$9.9B
Viatris (VTRS)$9B
Medpace Holdings (MEDP)$9B
Sonic Healthcare (SKHHY)$7.7B
HealthEquity (HQY)$7.3B
Charles River Laboratories (CRL)$5.2B
Amplifon S.p.A (AMFPF)$4.3B
Bausch + Lomb (BLCO)$4.3B
Alignment Healthcare (ALHC)$3.5B
Sotera Health (SHC)$3B
BrightSpring Health Services (BTSG)$2.9B
Organon (OGN)$2.9B
Surgery Partners (SGRY)$2.7B
GeneDx Holdings (WGS)$2.7B
Concentras Parent (CON)$2.6B
Progyny (PGNY)$1.8B
Ardent Health Partners (ARDT)$1.8B
Premier (PINC)$1.8B